← Back to Search

Artificial Pancreas System

CL/AP system for Type 1 Diabetes (T1DM AP Trial)

N/A
Waitlist Available
Led By Raimund Herzog, MD
Research Sponsored by Yale University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to 8-10 weeks
Awards & highlights

T1DM AP Trial Summary

This trial shows that a new insulin pump system can help prevent low blood sugar episodes and improve brain function in elderly people with Type 1 diabetes.

Eligible Conditions
  • Type 1 Diabetes

T1DM AP Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to 8-10 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 8-10 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Brain
Secondary outcome measures
Change in Cognitive Function: Grooved Pegboard Test
Change in Cognitive Function: MOCA
Change in Cognitive Function: Trail Test A
+1 more

T1DM AP Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: CL/AP systemActive Control1 Intervention
To improved glycemic control and strict avoidance of hypoglycemia via 8-week use of a CL/AP system (closed-loop/artificial pancreas) reverses brain metabolic adaptations in older adult T1DM patients.
Group II: usual carePlacebo Group1 Intervention
Subjects in this control group will continue their usual diabetic care (insulin pump therapy) along with CGM recording.

Find a Location

Who is running the clinical trial?

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH
2,359 Previous Clinical Trials
4,315,488 Total Patients Enrolled
Yale UniversityLead Sponsor
1,851 Previous Clinical Trials
2,738,206 Total Patients Enrolled
Raimund Herzog, MDPrincipal InvestigatorYale School of Medicine Department of Endocrinology
5 Previous Clinical Trials
171 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Using an Artificial Pancreas System in Older Adult Type 1 Diabetes Mellitus Patients
2017. "Using an Artificial Pancreas System in Older Adult Type 1 Diabetes Mellitus Patients". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03353792.
~1 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top